Ceritinib is a treatment specifically for ALK-positive metastatic non-small cell lung cancer. It works by focusing on the ALK signaling pathway. You take Ceritinib in capsule form.
The typical dose is 450 mg a day, taken with food once daily. One bottle has 70 capsules. It’ll last you about a month if you’re on the standard dose.
Ceritinib works by stopping the ALK protein. This protein makes cancer cells grow and spread in people with ALK-positive NSCLC. It’s a big part of the treatment plan for this type of lung cancer.
It’s like a more focused and usually easier to handle option than regular chemo. But you’ve got to take it just like your doc tells you to get the most out of it and keep the side effects low. Following your treatment plan and regular check-ins with your doc are really important for managing the illness.
Reviews
There are no reviews yet.